Due to its tumor-suppressive activity, Meflin is usually downregulated with patient’s age, and hypoxia, TGF-β signaling and promoting differentiation of pancreatic stellate cells into αSMA-positive myofibroblasts. Here, TGFB1 is linked to neoplasm.